Weed (BUDZ) Total Debt Growth (3y) (2022 - 2025)
Weed (BUDZ) Total Debt Growth (3y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 15.43% |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | -7.08% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 11.33% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -3.67% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -10.43% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | -13.72% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 92.83% |
| 10 | Weed | 2.88 Mn | 2.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 709.71% |
| Jun 30, 2025 | 707.90% |
| Mar 31, 2025 | 704.67% |
| Dec 31, 2024 | 759.54% |
| Sep 30, 2024 | 519.10% |
| Jun 30, 2024 | 503.61% |
| Mar 31, 2024 | 506.67% |
| Dec 31, 2023 | 119.35% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |